Global Market Industry Analysis Industry Growth Industry Trends Key Players Market Forecast Market Outlook Market Report Market Reports Market Research Market Sales Market Share Market Size News

Acne Vulgaris Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight

DelveInsight launched its new report on Acne Vulgaris Market Insights, Epidemiology, and Market Forecast-2030.


DelveInsight’s “Acne Vulgaris Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Acne Vulgaris , historical and forecasted epidemiology as well as the Acne Vulgaris market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some key facts of the report:

1. Acne Vulgaris affects ~85% of young adults aged 12–25 years.

2. Acne Vulgaris is ranked as the 8th most prevalent disease worldwide and is projected to affect approximately 9.4% of the global population.

3. Acne Vulgaris is observed to occur mostly in adolescence, but acne can persist upto the 20s and 30s in approximately 60% and 40% of individuals respectively.

4. Acne vulgaris is more common in females as compared to males.

Request for sample pages:

Key benefits of the report:

1. In the coming years, Acne Vulgaris market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
2. The companies and academics are working to assess challenges and seek opportunities that could influence Acne Vulgaris R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
3. Major players are involved in developing therapies for Acne Vulgaris. Launch of emerging therapies will significantly impact the Acne Vulgaris market
4. A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Acne Vulgaris

Acne Vulgaris is a common chronic skin disease involving blockage and/or inflammation of pilosebaceous units (hair follicles and their accompanying sebaceous gland). 


Moderate-to-severe inflammatory acne is characterized by the presence of nodules and cyst.


Acne vulgaris (AV) is a common chronic skin disease involving blockage and/or inflammation of pilosebaceous units (hair follicles and their accompanying sebaceous gland). Acne can present as noninflammatory lesions, inflammatory lesions, or a mixture of both, affecting mostly the face but also the back and chest. AV appears during early puberty when androgenic stimulation triggers excessive production of sebum and abnormal follicular keratinization, colonization by a Gram-positive bacterium (Propionibacterium acnes) and local inflammation.

Common symptoms of Acne Vulgaris are: whiteheads (closed plugged pores), blackheads (open plugged pores),small red, tender bumps (papules), pimples (pustules), large, solid, painful lumps beneath the surface of the skin (nodules), pus-filled lumps beneath the surface of the skin (cystic lesions).

Based on the extent of severity of acne, Acne Vulgaris is classified as:

  • Mild
  • Moderate
  • Severe


Request for sample pages


Key pharma players involved in Acne Vulgaris market are:

  1. Maruho
  2. Boston Pharmaceuticals
  3. Botanix Pharmaceuticals
  4. Vyome
  5. Novartis Pharmaceuticals
  6. And Many More


Drugs involved are:

  1. CLS001
  2. BOS-356
  3. BTX 1503
  4. VB-1953
  5. LYS006
  6. And Many More

Request for sample pages

Table of contents:

1. Key Insights
2. Executive Summary of Acne Vulgaris
3. Competitive Intelligence Analysis for Acne Vulgaris
4. Acne Vulgaris : Market Overview at a Glance
5. Acne Vulgaris : Disease Background and Overview
6. Patient Journey
7. Acne Vulgaris Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Acne Vulgaris Treatment
11. Marketed Products
12. Emerging Therapies
13. Acne Vulgaris : Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Acne Vulgaris
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Request for Detailed TOC:

Related reports:

Acne Vulgaris Pipeline Insight, 2020


Acne Vulgaris – Epidemiology Forecast to 2030